Company record · updated August 5, 2026
HGH Purchaser, Inc: 4 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs December 31, 2024 to December 31, 2025.
4observations
2source filings
4verified rows
2025-12-31most recent as-of date
Source rails for this company: BDC equity mark (4).
Reported by 1 filer: Crescent Capital BDC, Inc..
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2025-12-31 | price per share | 247.0024 USD | Crescent Capital BDC, Inc. | VERIFIED | Common Stock: 417 units / fair value 103 (declared thousands) | 0001193125-26-071922 |
| 2025-12-31 | price per share | 482.0144 USD | Crescent Capital BDC, Inc. | VERIFIED | Common Stock Class A: 417 units / fair value 201 (declared thousands) | 0001193125-26-071922 |
| 2024-12-31 | price per share | 482.0144 USD | Crescent Capital BDC, Inc. | VERIFIED | Common Stock Class A: 417 units / fair value 201 (declared thousands) | 0000950170-25-023153 |
| 2024-12-31 | price per share | 1,498.801 USD | Crescent Capital BDC, Inc. | VERIFIED | Common Stock: 417 units / fair value 625 (declared thousands) | 0000950170-25-023153 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.